Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
STR-V003
- Development stage
- Phase 2
- Lead developer
- Starna Therapeutics
- Modality
- mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
STR-V003 is an mRNA vaccine developed for the prevention of respiratory syncytial virus (RSV) infection. It consists of messenger RNA encoding the RSV prefusion F (preF) protein, encapsulated within lipid nanoparticles (LNPs). The vaccine induces robust and lasting immune responses, including high levels of neutralizing antibodies against both RSV A and B subtypes, and significantly reduces viral loads in animal models. STR-V003 demonstrated a favorable safety profile in preclinical studies, without causing vaccine-enhanced disease. It is currently undergoing phase 1 clinical evaluation in healthy adults for its safety, tolerability, and immunogenicity.
- Brand names
- STR-V003STR-V-003STR-V 003
- Other names
- STR-V003STR-V-003STR-V 003
02
Targets
RSV F (Respiratory syncytial virus fusion protein)
Beyond the preview
Go deeper on STR-V003.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on STR-V003.